Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Category - Pharmaceuticals
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
Libtayo Plus Chemotherapy Delivers Five-Year Survival Benefit in...
Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...
Glycomine Begins Global Phase 2b Clinical Trial of GLM101 for...
Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
Case Study: PostNord TPL ensures GDP compliance with Vaisala’s...
PostNord TPL, part of the PostNord Group, operates one of the largest third-party logistics...
AbbVie shares Phase 2 EPCORE® NHL-6 data: outpatient first-full...
AbbVie has reported updated results from the Phase 2 EPCORE® NHL-6 study (NCT05451810) assessing...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
Bayer Presents VICTOR Phase III Results for Vericiguat in Heart...
Bayer has shared new data from the VICTOR Phase III vericiguat heart failure trial in patients with...
Boehringer Ingelheim and AnGes Sign Manufacturing Agreement for...
Boehringer Ingelheim and AnGes have strengthened their long-standing collaboration with a new...
BioNTech Secures Non-Exclusive License Agreement with CureVac...
BioNTech has reached an agreement with CureVac and GSK to settle ongoing patent disputes and secure...